Pharmacokinetics and Pharmacogenetics of Cyclophosphamide in a Neonate and Infant Childhood Cancer Patient Population

• Váldodahkkit: Shelby Barnett (Dahkki), Julie Errington (Dahkki), Julieann Sludden (Dahkki), David Jamieson (Dahkki), Vianney Poinsignon (Dahkki), Angelo Paci (Dahkki), Gareth J. Veal (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Infants and young children represent an important but much understudied childhood cancer patient population. The pharmacokinetics and pharmacogenetics of the widely used anticancer prodrug cyclophosphamide were investigated in children <2 years of age. Concentrations of cyclophosphamide and selec...